Growth Metrics

Emergent BioSolutions (EBS) Amortization - Intangibles: 2018-2025

Historic Amortization - Intangibles for Emergent BioSolutions (EBS) over the last 8 years, with Sep 2025 value amounting to $16.3 million.

  • Emergent BioSolutions' Amortization - Intangibles changed 0.00% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year increase of 0.15%. This contributed to the annual value of $65.1 million for FY2024, which is 0.76% down from last year.
  • Emergent BioSolutions' Amortization - Intangibles amounted to $16.3 million in Q3 2025, which was up 0.62% from $16.2 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Amortization - Intangibles high stood at $17.9 million for Q4 2022, and its period low was $14.0 million during Q4 2021.
  • For the 3-year period, Emergent BioSolutions' Amortization - Intangibles averaged around $16.3 million, with its median value being $16.3 million (2023).
  • Per our database at Business Quant, Emergent BioSolutions' Amortization - Intangibles increased by 27.86% in 2022 and then dropped by 9.50% in 2023.
  • Emergent BioSolutions' Amortization - Intangibles (MRQ) stood at $14.0 million in 2021, then grew by 27.86% to $17.9 million in 2022, then fell by 9.50% to $16.2 million in 2023, then increased by 0.62% to $16.3 million in 2024, then decreased by 0.00% to $16.3 million in 2025.
  • Its Amortization - Intangibles was $16.3 million in Q3 2025, compared to $16.2 million in Q2 2025 and $16.3 million in Q1 2025.